Abstract:Yunfang Luo, 1, * Fang Yu, 1, * Xianjing Feng, 1 Di Liao, 1 Yuanlin Ying, 1 Xi Li, 1 Qin Huang, 1 Zeyu Liu, 1 Minping Wei, 1 Tingting Zhao, 1 Lin Zhang, 1 Ruxin Tu, 1 Jian Xia 1– 3 1 Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; 2 Clinical Research Center for Cerebrovascular Disease of Hunan Province, Central South University, Changsha, Hunan, People's Republic of China; 3 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China *These authors contributed equally to this work Correspondence: Jian Xia Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China Tel +86 731 84327216 Fax +86 731 84327401 . Email Purpose: Previous studies have shown a rising incidence of early-onset symptomatic intracranial atherosclerosis (sICAS), which has brought a severe economic burden to social development. This study aimed to evaluate the molecular biomarkers associated with early-onset sICAS and to seek possible intervention strategies for early prevention. Patients and Methods: We consecutively recruited patients with sICAS and divided them into two groups based on age: early-onset sICAS group as age ≤ 60 years old and late-onset sICAS group as age > 60 years old. We collected and compared the demographic data and laboratory results of each group. A bivariate logistic regression model was applied to evaluate the independent molecular biomarkers of early-onset sICAS. Results: A total of 1007 subjects with sICAS were enrolled in this study, comprising 519 patients in the early-onset sICAS group and 488 patients in the late-onset sICAS group. Bivariate logistic regression analysis demonstrated an increased level of white blood cell, platelet, albumin globulin ratio, free triiodothyronine, and a decreased level of total bile acid, urea nitrogen, high-density lipoprotein, homocysteine, and fibrinogen in the early-onset sICAS group when compared to the late-onset group. Conclusion: Our study showed the relevance between early sICAS and circulating levels of different molecular biomarkers. Detection of these related molecular biomarkers may provide a simple way for early sICAS preventions in the future. Keywords: ischemic stroke, symptomatic intracranial atherosclerosis, molecular biomarkers Intracranial atherosclerosis (ICAS) is the leading cause of ischemic stroke around the world. ICAS could be symptomatic or asymptomatic, and the symptomatic intracranial atherosclerosis (sICAS) refers to the ischemic stroke or transient ischemic attack (TIA) that occurs in the stenosis area of the supplying artery. 1 sICAS is associated with higher rates of severe symptoms, recurrence and rehospitalization. 2–5 A recent study showed that 45%-62% of patients with ischemic stroke had intracranial plaque and stenosis. 6 Generally, age is an independent risk factor for sICAS, and the incidence of sICAS increases in the elderly. 7 However, the occurrence of sICAS has shown a younger trend in recent years. Several studies have shown that risk factors are more complex and patients are more prone to worse prognosis in early-onset sICAS than in late-onset sICAS. 8–10 Early-onset sICAS affects patients' quality of life and ability to work, and thus brings a heavy economic burden to the family and society. In the past two decades, several researchers have sought to determine biomarkers correlated with sICAS, such as adipokines, interleukin-6, C-reactive protein, and matrix metalloproteinases. 11 What's more, laboratory indicators including white blood cells, platelets, albumin/globulin ratio, and free triiodothyronine are considered to be independent risk factors for intracranial atherosclerotic diseases. 12–14 The interaction among white blood cells, platelets and endothelial cells is the leading cause of inflammation and atherosclerosis. 15 However, serum albumin can attenuate the oxidative damage of atherosclerotic lesions. 16 High level of preoperative serum-free thyroxine 4 can be used as a sensitive and independent predictor of vascular restenosis in patients with angina pectoris afte -Abstract Truncated-

Metabolomics and Lipidomics Profiling in Asymptomatic Severe Intracranial Arterial Stenosis: Results from a Population-Based Study

Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.

Biomarker study of symptomatic intracranial atherosclerotic stenosis in patients with acute ischemic stroke

Non-traditional Lipid Parameters as Potential Predictors of Asymptomatic Intracranial Arterial Stenosis

Association between non-high-density-lipoprotein-cholesterol levels and the prevalence of asymptomatic intracranial arterial stenosis.

Association Between Metabolic Syndrome and Asymptomatic Cerebral Arterial Stenosis: A Cross-Sectional Study in Shandong, China

Prevalence And Risk Factors Of Asymptomatic Intracranial Arterial Stenosis In A Community-Based Population Of Chinese Adults

Prognostic value of mild asymptomatic intracranial atherosclerosis stenosis in patients with hypertension

Stroke incidence and cognitive outcomes of intracranial atherosclerotic stenosis: study protocol for a multicenter, prospective, observational cohort study

Intracranial Atherosclerotic Stenosis Is Associated with Cognitive Impairment in Patients with Nondisabling Ischemic Stroke: A pCASL-Based Study

Abstract TP221: Progression of Intracranial Artery Stenosis and Cerebral Small Vessel Disease and Associations Between the Two Entities: A Prospective Community-Based Cohort Study

Association between High-density-lipoprotein-cholesterol Levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis

Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations

Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis

An automatic image segmentation scheme for phalanx and epiphyseal/metaphyseal region of interests

Low-density lipoprotein particle profiles compared with standard lipids measurements in the association with asymptomatic intracranial artery stenosis

The Monitoring and Clinical Significance of Sar1b, Apob and Mttp in Patients with Intracranial Atherosclerotic Stenosis

Intracranial artery stenosis magnetic resonance imaging aetiology and progression study: Rationale and design.

Association of Lipoprotein-Associated Phospholipase A2 Mass with Asymptomatic Cerebral Artery Stenosis.

Associations of high sensitivity C-reactive protein levels with the prevalence of asymptomatic intracranial arterial stenosis.